Philip Leder, MD
Professor Emeritus, Department of Genetics, Harvard Medical School, Boston, Massachusetts
An internationally celebrated geneticist, Dr. Leder’s fundamental discoveries involving the genetic causes of carcinogenesis have propelled innumerable successes in such scientific fields as cancer genetics, molecular biology, tumor biology, and biochemistry, among others.
Dr. Leder is well known for his initial studies with Marshall Nirenberg of the genetic code and the genetic basis of protein coding and production. He is also credited with the first attempt to genetically engineer a mouse model of cancer, initially termed “oncomouse,” and the subsequent first U.S. patent of an animal. These pioneering studies were the first ever conducted whereby known cancer-causing genes were experimentally injected into mice to research the resulting cancer type. They proved to be the catalyst for the exponential increase in experimental use of transgenic mouse models that followed and other advances in understanding cancer, its causes, and its treatment.
2003 Elected Fellow, American Association for the Advancement of Science2000 Albert Einstein Memorial Lecturer, Israel Academy of Sciences and Humanities1997 William Allan Medal, American Society of Human Genetics1990 Heineken Prize, Royal Netherlands Academy of Arts and Sciences1989 U. S. National Medal of Science, National Science Foundation1987 Albert Lasker Medical Research Award1986 Senior Researcher, Howard Hughes Medical Institute1981 Dickson Prize in Medicine, University of Pittsburgh1980 Professor of Genetics, Harvard Medical School1979 Elected Member, National Academy of Sciences, Washington, DC1972 Director, Laboratory for Molecular Genetics, National Institute of Health1960 MD, Harvard Medical School